The Third People's Hospital of Shenzhen (The Affiliated Shenzhen Third Hospital, Guangdong Medical College), Shenzhen, Guangdong, 518112, P.R. China.
Clinical medical research center, The Second Clinical Medical College of Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong, 518020, P.R. China.
Sci Rep. 2019 May 15;9(1):7429. doi: 10.1038/s41598-019-43648-y.
Avian Influenza A (H5N6) Virus causes severe influenza disease in humans and is manifested by acute respiratory distress syndrome, multi-organ failure, and high mortality rates. T cells recognize antigens specifically through a membrane protein T cell receptor (TCR). To ward off a wide variety of pathogens, the human adaptive immune system harbors a vast array of TCRs, which are collectively referred to as the TCR repertoire. The B cell receptor (BCR) is involved in inducing the humoral immune response. The generation of a diverse T cell and B cell repertoire is essential for protection against infection. In this study, multiplex PCR based on genomic DNA amplicons and Illumina high-throughput sequencing (HTS) were applied to study the characteristics and polymorphisms of the TRB and IGH repertoire in the peripheral blood mononuclear cells (PBMCs) from two H5N6 AIV patients and six healthy donors (NC). The CDR3 average length in the AIV group was different from the NC group. The TRBV12-3, TRBV12-4, and TRBV15 gene segments and TRBV30/TRBJ1-2, TRBV12-3/TRBJ1-1 and IGHV3-11/IGHJ6 gene segment pairings also exhibited a higher usage in the PBMCs of AIV donors and may provide more information for generating more effective T/B cell targeted diagnosis/protection strategies.
禽流感病毒 A (H5N6) 可导致人类发生严重流感,其临床症状表现为急性呼吸窘迫综合征、多器官衰竭和高死亡率。T 细胞通过细胞膜蛋白 T 细胞受体(TCR)特异性识别抗原。为了抵御各种各样的病原体,人类适应性免疫系统拥有大量的 TCR,这些 TCR 统称为 TCR 库。B 细胞受体(BCR)参与诱导体液免疫反应。产生多样化的 T 细胞和 B 细胞库对于预防感染至关重要。在这项研究中,基于基因组 DNA 扩增子的多重 PCR 和 Illumina 高通量测序(HTS)被应用于研究 2 例 H5N6 AIV 患者和 6 例健康供体(NC)外周血单个核细胞(PBMC)中 TRB 和 IGH 库的特征和多态性。AIV 组的 CDR3 平均长度与 NC 组不同。TRBV12-3、TRBV12-4 和 TRBV15 基因片段以及 TRBV30/TRBJ1-2、TRBV12-3/TRBJ1-1 和 IGHV3-11/IGHJ6 基因片段配对在 AIV 供体的 PBMC 中也表现出更高的使用率,可能为生成更有效的 T/B 细胞靶向诊断/保护策略提供更多信息。